Heart 2007;93:1226-1230
ACUTE CORONARY SYNDROMES
Effect of drug combinations on admission for recurrent myocardial infarction
1 Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands
2 SIR Institute for Pharmacy Practice and Policy, Leiden, The Netherlands
Dr M L Bouvy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands; m.l.bouvy{at}uu.nl
Objective: To determine the effect of the number of different drugs with adherence to medication of at least 70% on recurrent admission for myocardial infarction (MI) in patients with a history of MI.
Design: Nested case–control study in a dynamic cohort.
Setting: PHARMO database that contains pharmacy dispensing records and hospital discharge records of 350 000 Dutch citizens.
Subjects: All patients admitted to hospital for first MI (ICD-9 410) from 1991 to 2000 with at least a 30-day survival after admission. Cases were admitted for recurrent MI and were matched for age, sex, and year of admission with controls who did not have a recurrent MI.
Main outcome measure(s): Odds ratio with 95% CI for admission for recurrent MI. Exposure was the number of preventive drugs (antiplatelet agents, statins and ß blockers or ACE inhibitors) used for at least 70% of the time.
Results: 389 cases were matched with 2344 controls. The use of one drug was associated with a 6% odds reduction (95% CI 30% reduction to 28% increase) for admission for recurrent MI. The use of two or three drugs was associated with reductions of 26% and 41% (47% reduction to 3% increase and 6% to 63% reduction, respectively). Addition of one drug caused a 16% reduction (4% to 26%).
Conclusions: Multiple drug treatment decreases admissions for recurrent MI in patients with a history of MI. Every addition of a drug, regardless of drug class, reduces the risk even further. These results support the treatment strategies as applied in daily practice.
Abbreviations: CABG, coronary artery bypass grafting; CHF, chronic heart failure; MI, myocardial infarction; OR, odds ratio; PDC, percentage of days covered; PTCA, percutaneous transluminal coronary angioplasty
Keywords: myocardial infarction; secondary prevention; combination drug therapy
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Meijs, M F L, Bots, M L, Cramer, M J M, Vonken, E-J A, Velthuis, B K, van der Graaf, Y, Visseren, F L, Mali, W P T. M, Doevendans, P A, on behalf of the SMART Study group,
(2009). Unrecognised myocardial infarction in subjects at high vascular risk: prevalence and determinants. Heart
95: 728-732
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
